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Summary. The modal DNA values of 1465 tumours, together with other factors
of possible prognostic importance, were related to the survival of the patients, using
regression models (Kay, 1977). For most tumour sites except the testis, the distribu-
tions of modal DNA values were bimodal, with peaks at the diploid level and in the
triploid-tetraploid range. For all tumour sites except the cervix uteri, patients in the
low (near-diploid) range showed better survival; the reverse was true for squamous-
cell carcinoma of the cervix uteri. Other variables showed the following effects: for
all sites except the testis, younger patients showed a better survival; for the cervix
and corpus uteri, breast and ovary, increasing clinical stage was associated with
poorer survival. Where evaluated, histological grade appeared to be associated with
survival rate, the less well differentiated tumours having a worse prognosis, except
for the breast, where the reverse correlation was noted. For carcinoma ofthe bladder,
females had a poorer survival rate than males.
MEASUREMENTS of nuclear DNA con-
tent have been widely used to estimate the
approximate modal chromosome numbers
ofhuman tumours. It has previously been
shown that the modal DNA values of
tumours at most sites tend to fall into 2
groups: a near-diploid and a "high-ploidy"
group (the latter centred in the triploid
or hypotetraploid region), suggesting that
polyploidization has occurred in a propor-
tion of the tumours. It has further been
shown that the overall prognosis of the
2 groups differs for some tumour sites or
types (Atkin, 1971, 1972, 1976a and b;
Atkin & Richards, 1962).
In the present paper, a new analysis is
presented based on survival-data re-
gression models. This method allows the
inclusion ofmore cases, notbeingrestricted
to those followed up for arbitrary periods,
such as 5 years, and thus utilizes more
information.
MATERIALS AND METHODS
The distribution of the 1465 tumours
according to site and histological type is
shown in Table I. DNA measurements were
made on Feulgen-stained smears (prepared
from fresh tumour material obtained before
the start of treatment) using an integrating
microdensitometer as previously described
(Atkin et al., 1966; Atkin & Richards, 1956).
Amount of DNA was assessed in arbitrary
units (110=diploid level; 220=tetraploid
level). Usually the primary tumour was
studied, but a proportion ofthe specimens at
some sites were of metastatic tumour (see
Table I).
Wherever possible, the following informa-
tion was obtained on the cases: duration of
follow-up or survival; age and sex; clinical
stage (cervix and corpus uteri, ovary and
breast); histological grade (cervix and corpus
uteri, ovary, breast, alimentary tract and
bladder); presence or absence of regional
lymphnode metastases, verified histologicallyMODAL DNA VALUE IN HUMAN TUMOURS
TABLE I.-Distribution of the cases
according to tumour site or type
No. of cases
Carcinoma of:
Cervix uteri:
squamous cell
adenocarcinoma
adenoacanthoma
Corpus uteri
Breast
Ovary
Stomach
Colon and caectum
Rectum
Urinar~, bladder
491
33
60J
202
199 (21)*
90 (30)
18 (5)
64
66
61
Testis:
Malignant teratoma 17
Seminoma 4 I
Combined teratoma an(l seminoma 2J
Reticuloses:
Hodgkin's dlisease
Lymphosarcoma
Reticulum-cell sarcoma
Follicular lymphoma
Others
Other 8ite8:
Malignant melanoma
Carcinoma of:
bronchus
thyroid
prostate
vulva
vagina
oesophagus
kidney
tongue, mouth and larynx
Other squamous-cell carcinomas
Other adenocarcinomas
Sarcomas
Extragenital malignant
teratomas
Other malignanit tumours
26] 51
4
2
2J
14
8
4
12
9
7
5
9
10
9
5
11
6
(8)
(4)
(2)
(2)
(2)
(1)
1465 (75)
* l brackets: numberinwhich metastatic tuimouir
material only was obtainedt.
on the operation specimen (breast and large
bowel); and duration of symptoms (cervix
uteri).
Statistical analysis of survival data
Survival curves.-A summary of the sur-
vival data is provided by experimental
survival curves using the methods of Kaplan
& Meier (1958) on times from start of treat-
ment to death or "censoring".
Survival-time models-.To investigate the
relationship between survival experience and
DNA value, a mathematical model is postu-
lated and for each patient the probability of
survival beyond t (denoted Ft) expressed in
terms of t and the values of that patient's
independent variables (i.e. DNA value, age,
stage of disease, grade, etc.). Estimation of
model parameters from the data enables
584 direct interpretation of the effects of these
factors on survival.
The postulated model takes the form
Ft=exp[-ta exp (o+flix + . . . +Ppxp)]
where xl,. . .. xp are the values of the in-
dependent variables and a, Po, /l, ., p
are unknown parameters to be estimated
from the data. The sign and absolute value
3o of the , coefficients "measure" the effects of
the independent variables. A negative/posi-
tive coefficient means that patients w-ith
larger/smaller values of that independent
variable have preferred survival.
39 Analyses were undertaken within each site,
the strata definedby squamous-cellcarcinoma,
adenocarcinoma, and adenoacanthoma within
the cervix uteri site being incorporated oni
allowing between-stratum differences in the
value of a. A similar procedure was adopted
for the gastrointestinal tract to account for
stomach, colon/caecum and rectum grouping.
A priori biological considerations suggested
that the effect of DNA may depend on the
"distance" from the diploid or tetraploid
values. For each patient, therefore. the
independent variables were defined by
ro DNA < 165 XI I DNA>166
X2 = IDNA-1101
IO X3= QIDNA 220J
DNA > 166
DNA < 165
DNA < 165
DNA > 166
X4 =logloage
X5 =stage
O0 Grades 1 or 3
X6 1 Grade 2
rf0 Grades 1 or 2
X7 l_1 Grade 3
O0 male
I8 1 female
o 0 lymphnodes without metastases Xg= \1 lymphnodes w%ith metastases
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AMOUNT OF DNA (arbitrary units)
FIG. 1(a)
FIG. 1. Distribution of DNA modal values within sites.
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Clinical stage was recorded on a four-point
ordered scale and a single independent
variable allowed a "linear" stage effect in the
exponent of log Ft. The coefficients f6 and f7
of the dummy grade variables X6 and x7
"measure" the effect of G(rades 2 and 3
respectively compared to Grade 1 on survival
time. A negative/positive coefficient here
indicates that patients with the correspond-
ing grading have better/worse survival ex-
perience than those patients under Grade 1.
In addition, duration of symptoms (in
months) before treatment was included in
a subsequent analysis of the cervix uteri data.
For particular sites, of course, some of these
variables are not considered. A more general
class ofmodels ofthis type has been presented
by Cox (1972) while the Weibull form used
here has been used by Prentice (1973) and
Williams (1978), amongst others. This parti-
cular parametric form was initially chosen
because the data sets at several sites w%rere
quite small and, as pointed out by Williams
(1978), it is not clear that efficiency losses in
using the non-parametric form (Cox, 1972)
are negligible in such small samples. In
addition, checks using residuals from the
fitted models as discussed in Kay (1977)
indicated the Weibull assumptions to be
adequate. For further details regarding the
use of these models see the references
cited above in this section.
RESULTS
Distribution ofDNA values
Histograms of modal DNA values of
tumours at the different sites studied are
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shown in Fig. 1. The distributions are
generally bimodal, with peaks at the
diploid level and in the triploid-tetraploid
region. Testicular tumours are exceptional,
however, few having near-diploid values
and none being clearly hypodiploid, as
previously noted (Atkin, 1973). The pre-
cise form of the curve tends to vary from
site to site. Thus, ovarian and bladder
carcinomas are relatively more often hypo-
diploid and less often hyperdiploid than
tumours at the other sites. Similarly, the
DNA level of the second ("high-ploidy")
peak varies, being relatively low (in the
triploid rather than hypotetraploid region)
for ovarian and large bowel carcinomas.
Analysis of survival data
It is clear from the survival curves in
Fig. 2 that between-site differences exist
in the general shape of the curves, and for
1.0
0.9
0.8
I-
0.O
0
a
E
-
0.7
0.6
0.5
0.4
0.3
0.2
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this reason formal model fitting was car-
ried out separately within sites. Details of
the model fitting which used data on only
those patients who had information on all
relevant variables are given in Table II.
For several sites, notably corpus uteri
and breast, many patients were omitted
from this analysis as information was
missing on the independent variables. In
cases involving the corpus uteri this was
mainly caused by undefined stage, whilst
in data for the breast it was at least one of
stage, grade, or lymphnodes with/without
metastases, which was not defined. It was
felt in the latter case that these omissions
might bias the analysis and the breast site
data were considered further with
"dummy" binary variables defining pre-
sence (0)/absence (1) of information.
Parameter estimates and their standard
errors are given in Table III.
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FIG. 2(a)
FIa. 2.-Kaplan-Meier survival curves showing estimated survival proportions within each site/stratum.
SCC =squamous-cell carcinoma (Fig. 2a).
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For all sites except the cervix uteri,
patients in the low-DNA groups (DNA<,
165) had the better survival. Not all the
coefficients associated with distances away
from the diploid and tetraploid DNA
values approached significance, although
their values suggest that within the cervix
uteri, large bowel, bladder and reticuloses
sites near-diploid and near-tetraploid
DNA values are associated with poorer
survival, whilst in the corpus uteri, breast,
ovary and testis sites greater distance from
these values is associated with shorter
survival times.
The effects ofthe remaining independent
variables may be summarized as follows:
(a) All sites except testis: Younger patients
have better survival.
(b) Cervix uteri, corpus uteri, breast and
ovary: Increasing stage associated with
poorer survival.
(c) All sites except testis and reticuloses:
Increasing survival proportions asso-
ciated with histological gradings-
3-2->l (Cervix uteri,
bladder)
3-*1---+2 (Corpus uteri)
2-*3-->1 (Ovary)
1-*2-+3 (Breast)
large bowel,
The differences between Grades 1 and 2
in the corpus uteri site and 2 and 3 in
the ovary site are very small.
(d) Large bowel, bladder, and reticuloses:
Within the bladder site, females have
poorer survival. Only marginal differ-
ences are present in the remaining
relevant sites.
The reanalysis of the breast data con-
firmed the above conclusions relating to
breast site. The coefficients of the dummy
variables, however, indicate that patients
with no information on either stage, grade
or lymphnodes with/without metastases
have significantly worse survival.
The further analysis of the cervix uteri
data to include duration of symptoms
indicated that this factor is not of prog-
Reticuloses
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TABLE III. Estimated model parameters and (in brackets) estimated standard errors in
reanalysis ofbreast data
ct: 0092
(0.07)
fi: 0-338 P2: 0(020*** 03: 0((8 DNA
(0-319) (0 007) (0 007)
f4: 1-66 age
(1-06)
f5: 032 1j: 1 58**** stage
(0.13) (0 38)
f6: -0-24** 07: - 39 y2: 1.26*** grade
(0 35) (0 39) (0-44)
F(j 1-04**** Y3: 0.79*** lymph
(0-30) (0-30) inodes
For j=1,2,3, yj is coefficient of yj 0 iniformation available oIn associated variable Signfor ance
J P
=1,2,3, y <
is coefficient 5 otherwise
Significance (P) *< 0-1, **< 0-05, **< 0)[, ****< 0(fl).
nostic importance, the estimated co-
efficient of - 001 having a standard error
of 001.
DISCUSSION
Although the complete cytogenetic study
of a human tumour requires the detailed
and painstaking analysis of its chromo-
some changes, significant information re-
lating to these changes can readily be
obtained from DNA measurements on
interphase cells. Moreover, data can easily
be obtained with this technique on un-
selected series of cases, including those in
which mitoses are absent from the sample
of cells obtained for study. The present
results have only established tenuous
associations between DNA measurement
and prognosis at sites where the tumours
can be placed in one or other of 2
"ploidy groups".
Correlations between DNA value and
prognosis have been investigated by
Tavares et al. (1966), who found a rela-
tively poor prognosis for carcinomas ofthe
bladder and prostate when the DNA value
was near-triploid or near-hexaploid. The
data presented here show that different
sites differ both with respect to the form
of the distribution curve of DNA values of
randomly selected series oftumours and to
the relationship between the ploidy group
ofindividual tumours from agiven site and
their prognosis. A priori suggestions that
tumours with modal values at or close to
the diploid, and perhaps also to the tetra-
ploid level, have a different prognosis from
those within that ploidy group but depart-
ing substantially from these levels were
not supported conclusively. Nevertheless
individual trends, some of which ap-
proached significance, suggested that
tumours close to these euploid levels have
a slightly worse prognosis for the cervix
uteri, large bowel, bladder and reticuloses,
and a slightly better prognosis for the
corpus uteri, breast, ovary and testis.
Chromosome analysis using banding
techniques is of course a more discrimina-
ting as well as a more difficult technique
than Feulgen cytophotometry. Whether it
wvill prove more useful as a diagnostic or
prognostic guide, for example by enabling
a distinction to be made between near-
diploid tumours with slight chromosome
changes such as one or 2 trisomies or
translocations and those with more ex-
tensive changes remains to be seen.
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